Background Fracture of the proximal femur is the most feared complication of osteoporosis. Given the numerous physiological functions that magnesium performs in our body, in the literature there is a correlation between osteoporosis and low serum levels of magnesium. Aim Evaluate the incidence of hypomagnesemia in patients with lateral fragility fracture of the proximal femur, the possible correlation between serum magnesium levels and fractures, and the efectiveness of supplementing Sucrosomial® magnesium associated with therapeutic exercise on the outcome of these patients. Methods We divided the study into two parts. In the frst part, we assessed the preoperative incidence of hypomagnesemia in patients using a blood test. In the second part, patients with hypomagnesemia were divided, in the post-operative period, into two groups, who received, respectively, only therapeutic exercise or oral supplementation with sucrosomial magnesium associated with therapeutic exercise. Results Half of the patients with fragility femoral fracture had hypomagnesemia, with a higher incidence of the subclinical form. From the comparison between the two groups, the T1 treatment group showed a signifcant improvement in blood levels of magnesium (2.11±0.15 vs. 1.94±0.11; p<0.05), on the NRS scale (5.7±0.81 vs. 6.6±1.18; p<0.05), the Tinetti scale (17.3±1.15 vs. 15.2±2.98; p<0.05) and the SarQoL questionnaire (47.3±5.21 vs. 44.9±5.54; p<0.05). Conclusions More attention would be needed in the diagnosis and correction of subclinical hypomagnesemia and not just the simple and clinically evident one, including hypomagnesemia among the modifable risk factors for osteoporosis.

Scaturro Dalila, V.F. (2022). Does the association of therapeutic exercise and supplementation with sucrosomial magnesium improve posture and balance and prevent the risk of new falls?. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 34, 545-553 [10.1007/s40520-021-01977-x].

Does the association of therapeutic exercise and supplementation with sucrosomial magnesium improve posture and balance and prevent the risk of new falls?

Scaturro Dalila;Vitagliani Fabio
;
Terrana Pietro;Tomasello Sofia;Camarda Lawrence;Letizia Mauro Giulia
2022-03-01

Abstract

Background Fracture of the proximal femur is the most feared complication of osteoporosis. Given the numerous physiological functions that magnesium performs in our body, in the literature there is a correlation between osteoporosis and low serum levels of magnesium. Aim Evaluate the incidence of hypomagnesemia in patients with lateral fragility fracture of the proximal femur, the possible correlation between serum magnesium levels and fractures, and the efectiveness of supplementing Sucrosomial® magnesium associated with therapeutic exercise on the outcome of these patients. Methods We divided the study into two parts. In the frst part, we assessed the preoperative incidence of hypomagnesemia in patients using a blood test. In the second part, patients with hypomagnesemia were divided, in the post-operative period, into two groups, who received, respectively, only therapeutic exercise or oral supplementation with sucrosomial magnesium associated with therapeutic exercise. Results Half of the patients with fragility femoral fracture had hypomagnesemia, with a higher incidence of the subclinical form. From the comparison between the two groups, the T1 treatment group showed a signifcant improvement in blood levels of magnesium (2.11±0.15 vs. 1.94±0.11; p<0.05), on the NRS scale (5.7±0.81 vs. 6.6±1.18; p<0.05), the Tinetti scale (17.3±1.15 vs. 15.2±2.98; p<0.05) and the SarQoL questionnaire (47.3±5.21 vs. 44.9±5.54; p<0.05). Conclusions More attention would be needed in the diagnosis and correction of subclinical hypomagnesemia and not just the simple and clinically evident one, including hypomagnesemia among the modifable risk factors for osteoporosis.
mar-2022
Scaturro Dalila, V.F. (2022). Does the association of therapeutic exercise and supplementation with sucrosomial magnesium improve posture and balance and prevent the risk of new falls?. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 34, 545-553 [10.1007/s40520-021-01977-x].
File in questo prodotto:
File Dimensione Formato  
s40520-021-01977-x.pdf

accesso aperto

Descrizione: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/
Tipologia: Versione Editoriale
Dimensione 655.77 kB
Formato Adobe PDF
655.77 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/518480
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 15
social impact